Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by LongRun78on Oct 25, 2020 4:37pm
305 Views
Post# 31778899

Approximations based on Walmart parking lots testing sites

Approximations based on Walmart parking lots testing sitesFrom April (exact date is not mentioned) to "July 20, Walmart had stood up 357 active sites, having tested more than 155,000 people across the country, and more are on the way."
src:htps://corporate.walmart.com/facing-the-outbreak/testing

This April to July 20th is approximately a 3 months long elapse. If Collection Sites succeed to deploy 165 sites (a little less than half of 357 deployed in 3 months by Walmart) by the end of the year, numbers could be interesting. 

Walmart drain for sure more traffic than competitors. As described in the article, this is drive-thru sites operated by Walmart, not like Collection Sites operating directly with peoples. For those reasons, I don't think Collection sites will obtain same numbers. Still, take only 25% from 155 000, it could be close to 40 000 Covid tests sold (in 3 months, beginning from scratch like Walmart did). 

Regarding QuestCap Covid tests, there' s the one at 59$ and the other at 179 $. If 80% tests used are at 59$ (80% / 40 000 * 59) and the remaining 20 % at 179$ (20% / 40 000 * 179), this is a 3 320 000 $ potential sale until the end oh the year.

In fact the 179$ test could possibily be the one used by peoples covered by a health insurance, meaning 20% could easily be beaten.


<< Previous
Bullboard Posts
Next >>